These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34875506)

  • 41. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells.
    Chen Y; Zhou C; Abdelhamid M; Jung CG; Michikawa M
    J Biochem; 2023 Oct; 174(5):409-420. PubMed ID: 37488092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
    Holtzman DM; Bales KR; Tenkova T; Fagan AM; Parsadanian M; Sartorius LJ; Mackey B; Olney J; McKeel D; Wozniak D; Paul SM
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2892-7. PubMed ID: 10694577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps.
    Lee LC; Goh MQL; Koo EH
    Bioessays; 2017 Sep; 39(9):. PubMed ID: 28731260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective.
    Chu Q; Diedrich JK; Vaughan JM; Donaldson CJ; Nunn MF; Lee KF; Saghatelian A
    J Am Chem Soc; 2016 Aug; 138(30):9473-8. PubMed ID: 27379525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
    Corona AW; Kodoma N; Casali BT; Landreth GE
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ERβ and ApoE isoforms interact to regulate BDNF-5-HT
    Chhibber A; Zhao L
    Alzheimers Res Ther; 2017 Sep; 9(1):79. PubMed ID: 28934977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.
    To AW; Ribe EM; Chuang TT; Schroeder JE; Lovestone S
    PLoS One; 2011 Feb; 6(2):e16991. PubMed ID: 21347323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease.
    Tomiyama T; Corder EH; Mori H
    Cell Mol Life Sci; 1999 Oct; 56(3-4):268-79. PubMed ID: 11212354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular apolipoprotein E affects Amyloid Precursor Protein processing and amyloid Abeta production in COS-1 cells.
    Hass S; Weidemann A; Utermann G; Baier G
    Mol Genet Genomics; 2001 Jul; 265(5):791-800. PubMed ID: 11523796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
    Blue EE; Cheng A; Chen S; Yu CE;
    JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease.
    Blumenau S; Foddis M; Müller S; Holtgrewe M; Bentele K; Berchtold D; Beule D; Dirnagl U; Sassi C
    Sci Rep; 2020 Apr; 10(1):7103. PubMed ID: 32345996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
    Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
    Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts.
    Cedazo-Mínguez A; Wiehager B; Winblad B; Hüttinger M; Cowburn RF
    Neurochem Int; 2001 Jun; 38(7):615-25. PubMed ID: 11290387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
    Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
    J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.